- Pressemitteilung BoxID 497658
4th Berlin-Brandenburg Technology Forum "In vitro-Diagnostics und Bioanalysis"
Berlin-Brandenburg covers the full range of the in vitro-diagnostics value chain, from biomarker identification to clinical validation, from manufacturers to service providers. A significant number of internationally renowned research institutes, the Charité, being the largest university clinic in Europe, and more than 80 diagnostics companies contribute to being one of Germany's hot spots for diagnostics development.
Since 2009, the Berlin-Brandenburg Technology Forum "In vitro-Diagnostics and Bioanalysis" has been proving to be an excellent platform for initiating a sustainable dialogue between fundamental research, industrial development and clinical application.
The 4th Technology Forum focuses on the impact of new technology platforms and next generation sequencing on the development of diagnostics, as well as on the biomarker development strategies, and the perspectives for personalized medicine.
A specially designed partnering event for diagnostics companies and research institutes facilitates to meet new cooperation partners from Europe and aims at fostering and encouraging possible growth opportunities.
Participants will have the opportunity to join a guided science tour in Berlin on June 7th (please indicate your interest in the registration form).
The Technology Forum 2012 will be once again the place to be for discussing new trends and topics in the field of in vitro-diagnostics.
Prior registration is requested. Participation in the Technology Forum is free of charge. The partnering event costs Euro 60,00 plus VAT.
Registration for the PARTNERING EVENT (Euro 60,00 plus VAT, scientific lecture program included)
Registration for the SCIENTIFIC LECTURE PROGRAM (free of charge)
Charité Campus Virchow Klinikum
Building "Lehrgebäude" · Lecture Hall 1
Augustenburger Platz 1
Further information (Hotel/Travel): www.zmdb.de/technologyforum2012/
Diese Pressemitteilungen könnten Sie auch interessieren
Roche's Rapid Mycoplasma Detection Test MycoTOOL Receives Acceptance from Canadian Authorities for Release Testing of Biopharmaceutical Roche Product
Today Roche announced that the Canadian Health Authority has accepted the use of its PCR based mycoplasma detection test MycoTOOL for release testing of one of Roche's...
Eine sichere Rohstoffversorgung ist für die deutsche Industrie von existenzieller Bedeutung. Aufgrund der stetig wachsenden Nachfrage von Rohstoffen stellt der Abbau...
Roche today announced the global launch of its SeqCap EZ Pure Capture Bead Kit supporting target enrichment workflows prior to DNA sequencing. The newly introduced...